The Right Way to Use Analytics Isn’t for Planning
Harvard Business Review
JUNE 16, 2016
In July 2015, Novartis launched its new heart failure drug, Entresto, which Forbes in 2014 predicted would be a blockbuster — with expected sales of $10 billion annually — as the potential market in the US exceeds 5 million people with a heart failure condition. Laura Schneider for HBR. The failures continue.
Let's personalize your content